Xenografts (Patient Derived Xenograft & Cell Line Derived Xenograft)

Xenografts represent clinically significant tumor model in vivo for targeted therapy for Cancer Patients. With YBL being a huge repository of PDX models for various cancers and an expert on par with global standards, provides CRO and CMO services for developing and/or supplying PDX models developed in NOD-SCID or NSG mice. PDX can be shipped to your facility Cryopreserved or used in YBL-directed preclinical efficacy studies. YBL also provides CDX in similar approach.